1-3 of 3
David Bishop
Close
Sort by
Journal Articles

Co-Administration of 3 rd party Partially HLA Matched Cytomegalovirus Specific T Cells with Initial Antiviral Pharmacotherapy for Post-Transplant Viral Reactivation

Emily Blyth, B. MDHons), FRACP, FRCPA, PhD, Leighton Edward Clancy, PhD, Elissa Atkins, GIllian Huang, David Collins, David Bishop, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2051.
https://doi.org/10.1182/blood-2018-99-117417
Published: 2018
Journal Articles

3rd Party CMV-Specific T Cells Provide Long Term Protection Against Episodes of Recurrent CMV after Allogeneic Stem Cell Transplant Despite Lack of Persistence in Peripheral Blood

Emily Blyth, Barbara Withers, Leighton Edward Clancy, PhD, Agnes S. M. Yong, MDPhD, Christopher Fraser, MD, Jane Burgess, Renee Simms, Gloria Castellano Gonzalez, PhD, David Kliman, MBBS, Ming-Celine Dubosq, MD, David Bishop, Gaurav Sutrave, MBBS,, Chun Kei Kris Ma, PhDMBBS, Peter J. Shaw, MA,FRACP, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1919.
https://doi.org/10.1182/blood.V130.Suppl_1.1919.1919
Published: 2017
Journal Articles

Nongenomic signaling of the retinoid X receptor through binding and inhibiting Gq in human platelets

Leonardo A. Moraes, Karen E. Swales, Jessica A. Wray, Amilcar Damazo, Jonathan M. Gibbins, Timothy D. Warner, David Bishop-Bailey
Journal: Blood
Blood (2007) 109 (9): 3741–3744.
https://doi.org/10.1182/blood-2006-05-022566
Published: 2007
Includes: Supplemental data